Hikma Pharmaceuticals PLC
(LSE:HIK)
£
16.38
-0.11 (-0.67%)
Market Cap: 3.40 Bil
Enterprise Value: 4.65 Bil
PE Ratio: 12.43
PB Ratio: 1.89
GF Score: 88/100 
Full Year 2025 Hikma Pharmaceuticals PLC Earnings Presentation(pre-recorded) Transcript
Feb 26, 2026 / 07:00AM GMT
Release Date Price:
£13.73
(-16.89%)
Said Darwazah
Hikma Pharmaceuticals PLC - Executive Chairman of the Board, Interim Chief Executive Officer
Good morning everyone. I am very pleased to be speaking with you today. It is good to be in the CEO role again.
I want to kick off by focusing on four key things. The first is stability. I am laser focused on getting the group onto a stronger and more stable footing. I want to reassure our people, our investors, and all our stakeholders that we have a very strong business and many exciting opportunities ahead.
The second is agility. I want to rebuild a culture of quick decision making, flexibility, and
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers